Zygomycosis and Covid-19: a case report and an integrative review
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2025.221449Keywords:
Fungal infections, COVID-19, MurcomycosisAbstract
Objectives: This article aims to describe a case of mucormycosis and provide a brief overview of its association with COVID-19. Methods: A review of the medical literature was performed using Web of Science. The bibliometric survey in the main collection of Web of ScienceTM identified 41 articles. For the development of these articles 668 references were used, with an average of approximately 16 references per article. Results: The medical literature indicates an important link between mucormycosis and COVID, as well as an increased risk of this disease in patients with previous comorbidities, such as diabetes mellitus. There was also a significant increase in the number of cases in the last years of the pandemic. Conclusion: Health care professionals caring for critically ill COVID-19 patients should be aware of opportunistic infections that can complicate the course of the disease.
Downloads
References
Alastruey-Izquierdo A, Hoffmann K, de Hoog GS, Rodriguez-Tudela JL, Voigt K, Bibashi E, et al. Species Recognition and Clinical Relevance of the Zygomycetous Genus Lichtheimia (syn. Absidia Pro Parte , Mycocladus ). J Clin Microbiol. 2010 Jun;48(6):2154–70.
Binder U, Maurer E, Lass-Flörl C. Mucormycosis – from the pathogens to the disease. Clin Microbiol Infect. 2014 Jun;20:60–6.
Auberger J, Lass-Florl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother. 2012 Sep 1;67(9):2268–73.
Danion F, Aguilar C, Catherinot E, Alanio A, DeWolf S, Lortholary O, et al. Mucormycosis: New Developments into a Persistently Devastating Infection. Semin Respir Crit Care Med. 2015 Sep 23;36(05):692–705.
Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018 Apr 1;56(suppl_1):S93–101.
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, Temsah MH, Barry M, Al Mutair A, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021 Oct;49(5):833–53.
PATRÍCIA FRAGA BARROS. MUCORMICOSE ORAL: RELATO DE CASO CLÍNICO. 2018.
Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature. Mycopathologia. 2021 May;186(2):289–98.
Monte Junior ES do, Santos MEL dos, Ribeiro IB, Luz G de O, Baba ER, Hirsch BS, et al. Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report. Clin Endosc. 2020 Nov 30;53(6):746–9.
Prabhu S, Alqahtani M, Al Shehabi M. A fatal case of rhinocerebral mucormycosis of the jaw after dental extractions and review of literature. J Infect Public Health. 2018 May;11(3):301–3.
Pandiar D, Kumar NS, Anand R, Kamboj M, Narwal A, Shameena PM. Does COVID 19 generate a milieu for propagation of mucormycosis? Med Hypotheses. 2021 Jul;152:110613.
Brettholz AM, Mccauley SO. Mucormycosis: Early Identification of a Deadly Fungus. J Pediatr Oncol Nurs. 2018 Jul;35(4):257–66.
Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, et al. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome. Ophthal Plast Reconstr Surg. 2021 Mar;37(2):e40–80.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Andreza Oliveira Alves, Lady Jane da Silva Macedo, Luana Leal Cosmo Cardoso, Giuliano da Paz Oliveira, Antonione Santos Bezerra Pinto
This work is licensed under a Creative Commons Attribution 4.0 International License.
